Subcategory & Sub-subcategory
Specifications
- Dosage Form: Multi-particulate oral capsule platform combining minitablets, granules, and liquid-filled components to deliver 2-3 active ingredients or 3-4 distinct release rates within a single capsule.
- Bioavailability Enhancement: Adaptive formulation design avoids the need for post-Phase 1 reformulation by allowing release-rate and combination adjustments within the existing delivery platform, preserving established bioavailability and PK profiles.
- Scale Capability: Platform technology is designed for direct scale-up from early clinical formulations through commercial manufacturing without redesigning the core delivery system.
- Excipient Selection: Formulation building blocks include coated minitablets, functional granules, and liquid fills selected to independently tune the release rate of each active ingredient.
Leave your rating & comment